Skip to main content
. 2021 Jul 8;30:43–49. doi: 10.1016/j.ctro.2021.06.009

Table 1.

Baseline patient and treatment characteristics.

Characteristic Total Cohort (n = 278) PCI Administered (n = 196)* PCI Not Administered (n = 81)* p-value
Median age (years, range) 65.6 (38.7–90.6) 64.2 (38.7–85.0) 69.7 (44.9–90.6) <0.001
Stage (n, %) 0.58
 I 27 (11) 21 (12) 5 (7)
 II 28 (11) 20 (11) 8 (11)
 III 192 (78) 135 (77) 57 (81)
 Unknown 31 20 11
 ECOG status (n, %) 1.00
 0/1 235 (86) 165 (86) 69 (86)
 2/3 38 (14) 27 (14) 11 (14)
 Unknown 5 4 1
mCCI Score (n, %) 0.40
 0 176 (65) 128 (67) 47 (61)
 1+ 93 (35) 63 (33) 30 (39)
 Unknown 9 5 4
Paraneoplastic Syndrome (n, %) 0.20
 No 253 (93) 181 (94) 71 (90)
 Yes 19 (7) 11 (6) 8 (10)
 Unknown 6 4 2
Pre treatment brain imaging (n, %) 0.12
 CT 75 (28) 52 (28) 22 (27)
 MRI 174 (65) 124 (67) 50 (62)
 None 17 (6) 8 (4) 9 (11)
 Unknown 12 12 0
Radiotherapy Dose 0.43
 40 Gy/15 183 (66) 123 (63) 59 (73)
 45 Gy/30 BID 82 (29) 64 (33) 18 (22)
 60 Gy/30 3 (1) 2 (1) 1 (1)
 66 Gy/33 3 (1) 2 (1) 1 (1)
 Other 7 (3) 5 (3) 2 (2)
Chemotherapy (n, %) 0.29
 Concurrent 230 (83) 158 (81) 71 (88)
 Sequential 46 (17) 36 (19) 10 (12)
 Unknown 2 2 0
Brain Surveillance (n, %) 0.18
 MRI 155 (56) 115 (59) 40 (49)
 No-MRI 123 (44) 81 (41) 41 (51)
Brain Relapse Salvage Therapy (n, %)** 1.00
 WBRT 58 (88) 29 (88) 29 (88)
 SRS 8 (12) 4 (12) 4 (12)

Abbreviations: ECOG, Eastern Cooperative Oncology Group; PCI, prophylactic cranial irradiation; mCCI, modified Charlson Comorbidity Index; WBRT, whole brain radiotherapy; SRS, stereotactic radiosurgery

*

PCI status unknown for one patient

**

Only patient with brain relapse and received salvage therapy were included